ClinicalTrials.gg
RecruitingNCT05847985LANG-LBDUpdated Feb 4, 2026

Language and Lewy Body Diseases: Sentence Comprehension Problems and Modifying Noninvasive Brain Stimulation Treatment

An interventional study of transcranial direct current stimulation (tDCS) in Lewy Body Disease and Healthy Aging, sponsored by Masaryk University. Recruiting at 1 site in Czechia. Open to participants aged 60 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-04.

Sponsored by Masaryk University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started May 2023; still recruiting 3 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
60 Years to 80 Years
Sex
All
01

Study summary

Lewy body diseases (LBDs) represents a group of neurodegenerative disorders characterized by the abnormal accumulation of aggregates of α-synuclein protein leading to the formation of Lewy bodies (LB) and Lewy neurites resulting in cell death. LBDs consists of two major clinical entities - Parkinson's disease (PD) and dementia with LB (DLB). Vast majority of patients with LBDs either already have mild cognitive impairment (MCI) at the time of the diagnosis or will develop it during the course of the disease. Language dysfunctions in LBDs patients with MCI are often unrecognized, which are difficult to treat, but even subtle changes might lead to impairment of social and occupational functioning with profound effect on their quality of lives. Current pharmacological or surgical strategies are effective for tackling the motor issues of LBDs with very limited effects on other symptoms such as language dysfunctions. Therefore, non-pharmacological approaches are gaining more attention. One of these non-pharmacological strategies is the use of noninvasive brain stimulation (NIBS) techniques that are able to modulate the brain functions with the effects on human nervous system plasticity. In this proposed project the investigators aim to first describe specific alterations in the language domain in LBDs patients with MCI as compared to healthy controls (HC) and identify the neural underpinnings of these changes using novel combination of advanced multimodal imaging techniques and various analytical methods. Secondly, the investigators aim to use NIBS as a supervised and individualized home-based therapeutical approach to tackle the language dysfunctions.

02

Conditions studied

  • Lewy Body Disease
  • Healthy Aging

Browse trials for

03

In context

Lewy Body Disease

240 studies on the registry are indexed under Lewy Body Disease; 89 are open to participants now.

This study's planned enrollment of 90 is close to the median of 86 across 152 interventional studies indexed under Lewy Body Disease.

Browse Lewy Body Disease studies →

Lead sponsor

Masaryk University is the lead sponsor of 47 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • right-handedness
  • Czech as their first language
  • age (60-80 years)
  • presence of PD-MCI (Litvan et al. 2012) or MCI-LB (McKeith et al. 2020) for LBD subjects

Exclusion criteria

Exclusion Criteria:

  • cardio pacemaker
  • any MRI-incompatible metal in the body
  • epilepsy
  • any diagnosed psychiatric disorders
  • alcohol/drug abuse
  • for HC group the presence of LBDs or other neurodegenerative disorder or MCI/dementia
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
90 participants (estimated)

Study arms

  • No intervention
    Differences between LBDs patients and HC in regulation of language functions

    In this study, 25 LBDs patients and 25 HC will undergo neuropsychological assessment, speech and writing recording, and MRI (structural T1 sequences, sentence comprehension fMRI task, neuromelanin-sensitive MRI sequence, and resting state measurement). The HC group will be matched to the LBDs patients with MCI for gender and age.

  • Experimental
    Long-term effects of repeated sessions of home-based tDCS delivered via telepractice

    The investigators will use a parallel-group, double-blinded, randomized, sham-stimulation-controlled design. Forty LBDs patients will be randomized into two parallel groups, n = 20 subjects in each arm. For the active group, the investigators will use the stimulation protocol with the anode over the left IFG (cathode over the right supraorbital area, 2mA, 20 minutes). Participants will undergo a baseline assessment (A0, as described in arm 1); 10 stimulation sessions (in a two-week period); a follow-up assessment immediately after tDCS treatment (A1), and follow-up assessments 8 weeks (A2) after the baseline assessment. Each assessment will consist of a brief neuropsychological assessment, speech and writing recording and MRI scanning.

    Device: transcranial direct current stimulation (tDCS)

Interventions

  • Devicetranscranial direct current stimulation (tDCS)

    tDCS using electric currents to modulate underlying neurons

06

What researchers measure

Primary outcomes

  1. sentence comprehension performance - accuracy

    the investigators will study comprehension of syntactically complex sentences - accuracy in sentence comprehension task

    Time frame: through study completion, an average of 1 year

  2. sentence comprehension performance - reaction times

    the investigators will study comprehension of syntactically complex sentences - reaction times in sentence comprehension task

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. relation of sentence comprehension performance to cognitive performance

    the investigators will correlate sentence comprehension with cognitive functions: z-scores in following domains - memory, attention, executive function, visuospatial function and language function of Short Neuropsychological Battery (Bolcekova et al. 2020)

    Time frame: through study completion, an average of 1 year

  2. The neural underpinning of sentence comprehension deficits - sentence comprehension fMRI task data

    The investigators will identify connectivity differences between HC and LBDs patients with MCI in language-related domain-specific and domain-general networks. In the task-based fMRI study, LBDs patients with MCI will show reduced activation and altered functional connectivity within and between these large-scale cortical networks compared to HC.

    Time frame: through study completion, an average of 1 year

  3. The neural underpinning of sentence comprehension deficits - resting state data

    Abnormal intra- and inter-network dynamics will be apparent in resting-state fMRI of LBDs patients with MCI as compared to HC.

    Time frame: through study completion, an average of 1 year

  4. The neural underpinning of sentence comprehension deficits - structural MRI data

    LBDs patients with MCI will show structural changes in language-related domain-specific and domain-general networks with neural degeneration as assessed by NMS-MRI as compared to HC.

    Time frame: through study completion, an average of 1 year

  5. the long-term effects of repeated sessions of home-based tDCS on sentence comprehension - accuracy

    the investigators will investigate the long-term effects of repeated sessions of home-based tDCS on sentence comprehension of syntactically complex sentences - accuracy in sentence comprehension task (as was described in outcome 1)

    Time frame: On the beginning of the study, after completion of two-week stimulation a eight weeks after the baseline assessment

  6. the long-term effects of repeated sessions of home-based tDCS on sentence comprehension - reaction times

    the investigators will investigate the long-term effects of repeated sessions of home-based tDCS on sentence comprehension of syntactically complex sentences - reaction times in sentence comprehension task (as was described in outcome 2)

    Time frame: On the beginning of the study, after completion of two-week stimulation a eight weeks after the baseline assessment

  7. the long-term effects of repeated sessions of home-based tDCS on sentence comprehension - The neural underpinning of sentence comprehension deficits - resting state data

    the investigators will investigate the long-term effects of repeated sessions of home-based tDCS on resting state data (as was described in outcome 5)

    Time frame: On the beginning of the study, after completion of two-week stimulation a eight weeks after the baseline assessment

  8. the long-term effects of repeated sessions of home-based tDCS on sentence comprehension - The neural underpinning of sentence comprehension deficits - sentence comprehension fMRI task data

    the investigators will investigate the long-term effects of repeated sessions of home-based tDCS on sentence comprehension fMRI task data (as was described in outcome 4)

    Time frame: On the beginning of the study, after completion of two-week stimulation a eight weeks after the baseline assessment

  9. the long-term effects of repeated sessions of home-based tDCS on sentence comprehension - The neural underpinning of sentence comprehension deficits - structural MRI data

    the investigators will investigate the long-term effects of repeated sessions of home-based tDCS on structural MRI data (as was described in outcome 6)

    Time frame: On the beginning of the study, after completion of two-week stimulation a eight weeks after the baseline assessment

07

Study locations

1 of 1 sites recruiting
  • Masaryk University CEITEC
    Brno, 62500, Czechia
    Recruiting
    • Lubomira Novakova · Contact+420549497766
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2023 (actual). Primary completion is estimated for Dec 2026, 43 months after the start.

Of 59 non-industry interventional studies with no phase under Lewy Body Disease, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 26 and three quarters within 53. This study's planned 43 months is above that.

Counting every sponsor, half of 63 studies reached it within 35 months; a quarter within 26 and three quarters within 56.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 13, 2023
First posted
May 8, 2023
StartActual
May 1, 2023
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Feb 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05847985
Lead sponsor
Masaryk University
Responsible party
Sponsor
First posted
May 8, 2023
Start date
May 1, 2023
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Feb 4, 2026

Study contacts

Lubomira Novakova
Contact
lubomira.novakova@ceitec.muni.cz
+420 549 497 766

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion